Taipei Exchange - Delayed Quote TWD

Lagis Enterprise Co., Ltd. (6730.TWO)

39.55 -0.95 (-2.35%)
At close: April 26 at 2:31 PM GMT+8
Key Events
Loading Chart for 6730.TWO
DELL
  • Previous Close 40.50
  • Open 39.40
  • Bid 39.40 x --
  • Ask 41.00 x --
  • Day's Range 39.40 - 41.00
  • 52 Week Range 36.25 - 50.20
  • Volume 4,130
  • Avg. Volume 29,579
  • Market Cap (intraday) 1.266B
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) 19.97
  • EPS (TTM) 1.98
  • Earnings Date --
  • Forward Dividend & Yield 1.80 (4.39%)
  • Ex-Dividend Date Jul 26, 2023
  • 1y Target Est --

Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and related accessories. The company was founded in 1993 and is headquartered in Taichung, Taiwan.

www.lagis.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 6730.TWO

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6730.TWO
4.08%
TSEC weighted index
12.21%

1-Year Return

6730.TWO
3.43%
TSEC weighted index
30.90%

3-Year Return

6730.TWO
8.13%
TSEC weighted index
16.30%

5-Year Return

6730.TWO
--
TSEC weighted index
73.76%

Compare To: 6730.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6730.TWO

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    1.31B

  • Enterprise Value

    1.40B

  • Trailing P/E

    20.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.89

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    3.49

  • Enterprise Value/EBITDA

    15.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.59%

  • Return on Assets (ttm)

    4.71%

  • Return on Equity (ttm)

    9.10%

  • Revenue (ttm)

    400.52M

  • Net Income Avi to Common (ttm)

    46.43M

  • Diluted EPS (ttm)

    1.98

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    58.15M

  • Total Debt/Equity (mrq)

    7.15%

  • Levered Free Cash Flow (ttm)

    -111.23M

Company Insights: 6730.TWO